Hikma Pharmaceuticals PLC 2021 AR2
The report highlights Hikma's strong financial and non-financial performance in 2021, with Group revenue growing 9% to $2,553 million. Key achievements include establishing a target to reduce Scope 1 and 2 greenhouse gas emissions by 25% by 2030 compared to a 2020 baseline. The company also expanded its product portfolio with 172 new launches and advanced its diversity, equity, and inclusion initiatives by establishing Employee Resource Groups. Additionally, Hikma demonstrated strong community commitment by donating $3.2 million in medicines and completing nearly 8,300 hours of employee volunteering.
Company: Hikma Pharmaceuticals PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2021
Type: AR2
Pages: 97
Back to company
Hikma Pharmaceuticals PLC
Annual Report
The report highlights Hikma's strong financial and non-financial performance in 2021, with Group revenue growing 9% to $2,553 million. Key achievements include establishing a target to reduce Scope 1 and 2 greenhouse gas emissions by 25% by 2030 compared to a 2020 baseline. The company also expanded its product portfolio with 172 new launches and advanced its diversity, equity, and inclusion initiatives by establishing Employee Resource Groups. Additionally, Hikma demonstrated strong community commitment by donating $3.2 million in medicines and completing nearly 8,300 hours of employee volunteering.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Women on Board
Women in Management
Employees